Publication | Open Access

Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25–35 peptide administration in mice

Leucettine L41Neurodegenerative DiseasesDyrk1a-preferential Dyrks/clks InhibitorMedicineSynaptic TransmissionNeuropharmacologyPrevents Memory ImpairmentsDegenerative PathologyNeuroprotectionNeurosciencePharmacologySynaptic Signaling